Natera Inc (NTRA)

85.00 -5.59  -6.17% NASDAQ May 11, 08:40 USD
View Full Chart
Price Chart
View All NTRA News

News

View All Events

Events

Date Type Description
08/05/2021 00:00 Earnings Results Q2 2021 Earnings Results
08/05/2021 16:30 Earnings Calls Q2 2021 Earnings Call
05/06/2021 00:00 Earnings Results Q1 2021 Earnings Results
05/06/2021 16:30 EDT Earnings Calls Q1 2021 Earnings Call
02/25/2021 00:00 Earnings Results Q4 2020 Earnings Results
02/25/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 00:00 Earnings Results Q3 2020 Earnings Results
11/05/2020 16:30 EST Earnings Calls Q3 2020 Earnings Call
08/05/2020 16:30 EDT Earnings Calls Q2 2020 Earnings Call
08/05/2020 00:00 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing the genetic features of a fetus. Natera's array of diagnostic services include Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic, or a patient for the test upon delivery of the test result.
  • URL: https://www.natera.com
  • Investor Relations URL: http://investor.natera.com/phoenix.zhtml?c=254055&p=irol-irhome
  • HQ State/Province: Texas
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Aug. 05, 2021
  • Last Earnings Release: May. 06, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
GNOM Global X Genomics & Biotechnology ETF 5.38%
AOFCX Alger Small Cap Focus C 4.78%
WGFCX Wells Fargo Growth C 2.42%
LADQX Lord Abbett Developing Growth R2 1.78%
JGLYX JPMorgan Small Cap Growth R4 1.74%
ASG Liberty All-Star Growth 1.68%
DCCRX Delaware Small Cap Core R 1.29%
FKBSX Federated Hermes Kaufmann Small Cap B 1.04%
IWO iShares Russell 2000 Growth ETF 0.53%
VTWG Vanguard Russell 2000 Growth ETF 0.52%
VTWO Vanguard Russell 2000 ETF 0.27%
IWM iShares Russell 2000 ETF 0.27%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.